|
2024
|
Invention
|
Kit for preventing or treating filovirus and flavivirus diseases.
A kit for reducing the risk of... |
|
|
Invention
|
Antibodies against slam family member 7 and uses thereof. Therapeutic blockade of inhibitory immu... |
|
2023
|
Invention
|
Subject-specific tumor inhibiting cells and the use thereof.
This disclosure is directed to a ph... |
|
|
Invention
|
Method for reducing hepatic triglycerides.
A method of reducing the level of hepatic triglycerid... |
|
|
Invention
|
Method for reducing hepatic triglycerides. A method of reducing the level of hepatic triglyceride... |
|
2021
|
Invention
|
Kits for preventing and treating ebola.
A kit for reducing the risk of filovirus hemorrhagic fev... |
|
2019
|
Invention
|
Stabilized osteocalcin and uses thereof. 23456789111213141519252627303133363740424344454748291115... |
|
|
Invention
|
Method of reducing neuronal microtubule binding protein tau (tau) levels. There is provided a met... |
|
|
Invention
|
Recombinant nervous system cells and methods to generate them.
The instant disclosure provides a... |
|
|
Invention
|
Recombinant nervous system cells and methods to generate them. The instant disclosure provides a ... |
|
|
Invention
|
Methods of preventing or treating non-hematopoietic slamf7 positive and slamf7 negative cancers. ... |
|
2018
|
Invention
|
Subject-specific tumor inhibiting cells and the use thereof. This disclosure is directed to a pha... |
|
|
Invention
|
A subcutaneous pharmaceutical preparation comprising insulin(s) and an anti-inflammatory agent to... |
|
|
Invention
|
Methods of preventing or treating filovirus and flavivirus diseases. A method of reducing the ris... |
|
2017
|
Invention
|
Methods of preventing or treating slamf7 positive and slamf7 negative cancers.
A method for the ... |
|
|
Invention
|
Methods of preventing or treating slamf7 positive and slamf7 negative cancers. A method for the p... |
|
2016
|
Invention
|
Modulating uracil-dna glycosylase and uses thereof.
The present invention concerns a method for ... |
|
|
Invention
|
Modulating uracil-dna glycosylase and uses thereof. The present invention concerns a method for t... |
|
2015
|
Invention
|
Type 2 diabetes biomarkers and uses thereof. The present invention provides biomarkers, methods a... |
|
2014
|
Invention
|
Small molecule modulators of pcsk9 and methods of use thereof.
A compound of Formula (I): or a p... |
|
|
Invention
|
Small molecule modulators of pcsk9 and methods of use thereof. A compound of Formula (I): or a ph... |
|
2012
|
Invention
|
Single domain antibodies as inhibitors of pcsk9. Antibodies (e.g., sdAbs) binding to PCSK9 are de... |
|
|
Invention
|
Modulation of the sonic hedgehog pathway and uses thereof.
A method for modulating Sonic hedgeho... |
|
|
Invention
|
Chimeric pcsk9 proteins, cells comprising same, and assays using same. A chimera protein comprisi... |
|
2011
|
Invention
|
Modulating and/or detecting activation induced deaminase and methods of use thereof.
A method fo... |
|
2009
|
Invention
|
Method for targeted cell ablation.
The present technology relates to a method fo... |
|
2008
|
Invention
|
Mutated hoxb4 proteins with improved stability, and methods of use thereof. A polypeptide, the am... |
|
2007
|
Invention
|
Pcsk9 polypeptide, ligand to said polypeptide, kits and methods using said ligands.
T... |
|
2001
|
Invention
|
Hematopoietic stem cell expansion enhancing factor and method of use.
The present inv... |
